Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2003
12/03/2003EP1366012A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
12/03/2003EP1365842A2 Inflammatory cytokine secretion inhibition
12/03/2003EP1365812A2 Pharmaceutical composition having reduced tendency for drug crystallization
12/03/2003EP1365800A2 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/03/2003EP1365793A2 Treatment of inflammatory bowel disease using growth factors
12/03/2003EP1365788A2 Thrombomodulin analogs for use in recovery of signal cord injury
12/03/2003EP1365787A2 New uses for amino acid anticonvulsants for treatment of pain
12/03/2003EP1365778A2 Treating pulmonary disorders with gaseous agent causing repletion of gsno
12/03/2003EP1365777A2 Proteoglycan compositions for treatment of inflammatory conditions
12/03/2003EP1365769A1 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
12/03/2003EP1365752A2 Methods for the treatment of a traumatic central nervous system injury with e.g. allopregnanolone
12/03/2003EP1365737A2 Stable salts of o-acetylsalicyclic with basic amino acids
12/03/2003EP1365645A2 Transgenic mice containing targeted gene disruptions
12/03/2003EP1257555B1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/03/2003EP1082304B1 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)
12/03/2003EP1027351B1 Phenanthroline derivatives
12/03/2003EP1015437B1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
12/03/2003EP0976748B1 Pyrrolidine derivatives having phospholipase a2 inhibitory activity
12/03/2003CN1460108A Water soluble rapamycin esters
12/03/2003CN1460101A Novel compounds inhibiting factor Xa activity
12/03/2003CN1460025A Immunomodulatory human MHC class Ôàí antigen-binding polypeptides
12/03/2003CN1460023A Polymer-modified bioactive sythetic chemokines, and method for their mfg. and use
12/03/2003CN1460013A 局部凝胶给药体系 Topical gel delivery system
12/03/2003CN1459459A Preparation and assaying of peptide dextran possessing detectable oral absorption immune regulation of rainbow conk
12/03/2003CN1459315A Biodegradation type introducing agent of hardly water-soluble steroid, nonsteroid anti-inflammatory medicine, and its prepn. method
12/03/2003CN1459314A Composition for preventing and treating milk cow from bateria disease
12/03/2003CN1459308A Series medicines for treating headache
12/03/2003CN1459305A Medicine for treating chronic pain, and its prepn. method
12/03/2003CN1459294A Traditional Chinese medicine tincture for reducing inflammation and relieving pain
12/03/2003CN1459286A Tetrodotoxin respiratory tract administration prepn. used for giving-up drug and easing pain
12/03/2003CN1459284A Neohouttuynin sodium freeze-dried powder-injection, and its prepn. method
12/03/2003CN1129606C Heptapeptide oxytocin analogues
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129603C Heterocycles, its preparation, application and medicine contanining same
12/03/2003CN1129593C Method for prepn of citalopram
12/03/2003CN1129577C 维生素d3衍生物 Derivatives of vitamin d3
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/03/2003CN1129450C Medicine for clearing away heat and toxic material and its prepn.
12/03/2003CN1129449C Pain treatnig composite medicine
12/03/2003CN1129429C Potassium sodium and tris oxaprozin salt pharmaceutical formulations
12/02/2003US6657047 Nucleotide sequences coding polypeptide for use in the treatment of tumors, inflammation, psoriasis, rheumatoid arthritis, cardiovascular and vision disorders
12/02/2003US6656966 Nitrosated and nitrosylated taxanes, compositions and methods of use
12/02/2003US6656964 Reducing levels of tumor necrosis factor alpha; inhibition of undesireable levels of matrix metalloproteinases
12/02/2003US6656959 PDE IV inhibiting pyridine derivatives
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656942 Orally active salts with tyrosine kinase activity
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656938 Inducing cytokine biosynthesis in animals, for the treatment of diseases, including viral and neoplastic diseases
12/02/2003US6656937 Substituted glutarimides and their use as inhibitors of IL-12 production
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003US6656932 Treating osteoarthritis, rheumatoid arthritis, cancer, inflammation, and heart failure
12/02/2003US6656905 Cyclic tetrapeptide compound and use thereof
12/02/2003US6656713 Compounds and methods for modulating activation of NF-κB
12/02/2003US6656707 Nucleic acid molecules encoding the same; vectors, host cells, pharmaceutical compositions, selective binding agents and methods for production; antagonists and agonists; bactericides; viricides
12/02/2003US6656504 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
12/02/2003US6656503 Counters ulcerogenic side effects; nonsteroidal antiinflam-matory core with polymer and misoprostol coating
12/02/2003US6656482 Spill resistant pharmaceutical system
12/02/2003US6656473 Defatted meal from squash seeds containing protein-bound tryptophan and carbohydrate source (glucose, maltose, sucrose) for facilitating transport across the blood brain barrier; useful for inducing sleep
12/02/2003US6656472 Multi oligosaccharide glycoconjugate bacterial meningitis vaccines
12/02/2003US6656459 Compositions of non-ionic block copolymers to treat autoimmune and inflammatory diseases, and to reduce graft/implantation, and methods of use thereof
12/02/2003CA2254061C Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
12/02/2003CA2075201C Use of an .alpha.-tocopherol phosphate or a derivative thereof for preparing cosmetic, dermatological or pharmaceutical compositions, and compositions thereby obtained
11/2003
11/27/2003WO2003098385A2 System and method for transparent early detection, warning, and intervention during a medical procedure
11/27/2003WO2003097852A2 Assay for identifying inhibitors of fc gamma riii signaling
11/27/2003WO2003097849A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003WO2003097806A2 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097659A1 6-11 bicyclic ketolide derivatives
11/27/2003WO2003097658A2 Compounds and methods for inhibiting selectin-mediated function
11/27/2003WO2003097649A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/27/2003WO2003097648A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof
11/27/2003WO2003097645A1 5-ethylimidarotriazones
11/27/2003WO2003097639A1 Benzoxazine and benzoxazinone substituted triazoles
11/27/2003WO2003097633A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
11/27/2003WO2003097622A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
11/27/2003WO2003097621A1 Methods of using thiazolidinedithione derivatives
11/27/2003WO2003097620A1 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
11/27/2003WO2003097608A2 Opioid and opioid-like compounds and uses thereof
11/27/2003WO2003097602A1 Cyanoguanidine produgs
11/27/2003WO2003097601A1 Cyanoguanidine prodrugs
11/27/2003WO2003097597A2 Indole derivatives and the use thereof as cb2 receptor ligands
11/27/2003WO2003097591A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003097582A2 Synthesis of benzonitriles and benzimidates
11/27/2003WO2003097573A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
11/27/2003WO2003097564A2 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
11/27/2003WO2003097104A1 Treatment and prevention of tissue damage
11/27/2003WO2003097082A2 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
11/27/2003WO2003097073A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/27/2003WO2003097071A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
11/27/2003WO2003097069A1 Trimegestone and estrogens for treating post menopausal disorders
11/27/2003WO2003097062A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003WO2003097053A1 Compounds, compositions, and methods
11/27/2003WO2003097052A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/27/2003WO2003097047A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003WO2003097040A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003WO2003097030A1 Use of 4-(4'-aminophenylsulphonyl)-benzoic acid and esters thereof as anti-inflammatory agents
11/27/2003WO2003097019A1 Multilamellar system for the administration of active agents by means of ingestion
11/27/2003WO2003097009A1 Injection formulation
11/27/2003WO2003066594A3 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
1 ... 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 ... 1272